Zortress 1 mg/1

Zortress 1 mg is an oral tablet containing everolimus, used for immunosuppressive therapy. This medication helps manage organ transplant rejection by modulating the immune response.

Zortress 1 mg is primarily used to prevent organ rejection in transplant patients. Everolimus, the active ingredient, works by suppressing the immune system to help the body accept the transplanted organ. This medication is often prescribed in combination with other immunosuppressants to enhance effectiveness.

Common effects of Zortress 1 mg may include mild to moderate side effects such as headaches, fatigue, and gastrointestinal discomfort. Some users may experience swelling or infections due to the immune-suppressing nature of the drug. Always consult a healthcare provider for personalized advice.

Zortress 1 mg should be handled with care, especially regarding dosage and administration. It is important to follow the prescribed regimen to avoid potential complications. Patients should monitor for signs of infection or unusual swelling and report any concerns to their healthcare provider.

Zortress 1 mg may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. Alcohol and other immunosuppressants can also affect its efficacy. Always inform your healthcare provider about all medications you are taking to avoid adverse interactions.